BRIACELL THERAPEUTICS CORP's ticker is and the CUSIP is 10778Y902. A total of 3 filers reported holding BRIACELL THERAPEUTICS CORP in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $42 | -84.9% | 6,600 | -82.4% | 0.00% | – |
| Q1 2023 | $278 | -18.5% | 37,400 | -52.2% | 0.00% | – |
| Q4 2022 | $341 | -99.9% | 78,200 | -15.4% | 0.00% | -100.0% |
| Q3 2022 | $519,000 | +19.9% | 92,400 | +22.9% | 0.00% | – |
| Q2 2022 | $433,000 | -31.8% | 75,200 | +19.9% | 0.00% | -100.0% |
| Q1 2022 | $635,000 | +68.0% | 62,700 | +37.2% | 0.00% | – |
| Q4 2021 | $378,000 | – | 45,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NATIONAL BANK OF CANADA /FI/ | 2,141 | $1,773,000 | 0.01% |
| SIMPLEX TRADING, LLC | 45,700 | $378,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |